Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -657.58% | 91.90% | 50.21% | 11.23% | -15.03% |
| Total Depreciation and Amortization | 66.37% | 5.45% | -10.86% | 45.25% | 7.75% |
| Total Amortization of Deferred Charges | 1.93% | 1.85% | 0.23% | 1.29% | -11.56% |
| Total Other Non-Cash Items | 185.88% | -2,745.61% | -101.84% | -14.91% | 29.73% |
| Change in Net Operating Assets | 113.93% | 61.17% | -70.58% | -370.89% | 45.69% |
| Cash from Operations | 58.95% | 60.12% | 10.04% | -12.67% | -6.90% |
| Capital Expenditure | 10.13% | -79.86% | 79.02% | -586.06% | 30.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -522.54% | -88.56% | -33.74% | 153.43% | -428.47% |
| Cash from Investing | -653.37% | -90.77% | -31.81% | 151.09% | -434.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.93% | -3.50% | -2.96% | -3.88% | 72.30% |
| Issuance of Common Stock | -12.59% | -7.61% | -12.48% | 1.40% | -96.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.03% | -7.91% | -12.83% | 1.34% | -96.11% |
| Foreign Exchange rate Adjustments | 193.73% | 48.10% | -8,000.00% | 100.72% | -197.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -296.02% | -152.16% | -59.16% | 118.50% | -207.77% |